A Risk Model for 28-Day in-Hospital Mortality in 173 COVID-19 Patients Admission to ICU: A Retrospective Study
Yiting Hua,Yutong Zhou,Ziyue Qin,Yuan Mu,Ting Wang,Haoyu Ruan
DOI: https://doi.org/10.2147/idr.s447326
2024-03-24
Infection and Drug Resistance
Abstract:Yiting Hua, 1, 2, &ast Yutong Zhou, 1, 2, &ast Ziyue Qin, 1, 2 Yuan Mu, 1, 2 Ting Wang, 1, 2 Haoyu Ruan 1, 2 1 Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 2 Branch of National Clinical Research Center for Laboratory Medicine, Nanjing, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haoyu Ruan; Ting Wang, Department of Laboratory Medicine, the First Affiliated Hospital, Nanjing Medical University, 300 Guang Zhou Road, Nanjing, Jiangsu Province, 210029, People's Republic of China, Email ; Background: The surge in the number of patients diagnosed with COVID-19 since China's open-door policy has placed a huge burden on the public healthcare system, especially the intensive care system. This study's objective was to discover possible clinical outcome predictors in COVID-19 patients treated in intensive care units (ICUs) and to provide useful information for future preventative efforts and therapies. Methods: This retrospective study included 173 COVID-19 critically ill patients and reviewed the 28-day survival outcome in the First Affiliated Hospital of Nanjing Medical University. Competing risk analysis was performed to predict the cumulative incidence function (CIF) of mortality in hospital. The independent prognostic factors were identified by applying the Fine–Gray proportional subdistribution hazard model. Receiver operating characteristic (ROC) curves were used to evaluate model efficacy, and calibration curves were used to validate the model. Finally, we compared the competing risk model with the traditional proportional hazards model (Cox regression model) using CIF. Results: Of these 173 patients, 66 (38.2%) survived, 55 (31.8%) died, and 52 (30.0%) discharged. In univariate analysis, 12 variables were significantly correlated with mortality. In multivariate analysis, Age, Neutrophil ratio, Direct Bilirubin (DBIL) and Renal disease were independent predictors of 28-day outcome. The ROC curve of the multivariate prediction model showed an AUC (area under the curve) of 0.790. The results of the calibration curve and the concordance index (C-index) show that the model has good discriminatory power. The competing risk model we applied was more accurate than the Cox model. Conclusion: We presented a more accurate multivariate prediction model for 28-day in-hospital mortality for ICU COVID-19 patients using a competing risk model. Keywords: COVID-19, 28-day mortality, competing-risk analysis, ICU COVID-19 pandemic has been one of the most severe problems for contemporary medicine and public health systems worldwidely since its emergency. 1,2 Symptoms vary in COVID-19 patients, ranging from asymptomatic to severe pneumonia, acute respiratory distress syndrome (ARDS), respiratory failure, or multi-organ failure. 3 According to early epidemiological reports, 80% of cases have only mild symptoms, 20% required hospitalization, and 4% further required intensive care unit treatment. 4 ICU COVID-19 patients demand more inclination of medical resources such as respiratory support, including invasive mechanical ventilation (IMV), noninvasive mechanical ventilation (NIV), and high-flow nasal cannula (HFNC) oxygen therapy, as well as specialized nursing staff, causing higher public health care burden. 5,6 Since December 2022, China has begun its epidemic liberalization policy. The number of infections has surged accordingly, which has brought huge burden on the health care system. ICUs have been fully loaded and even overloaded for patients with COVID-19. 7 Early identification of risk factors for critically ill patients with COVID-19 can help make medical decision for timely and effective management. 8,9 There have been many investigations trying to discover risk factors for the deaths of COVID-19 patients. 10–15 In a retrospective study including 2529 patients, researchers established a risk model of COVID-19 to predict in-hospital mortality and complications, and identify high-risk patients with poor prognosis, 16 which included old age, history of heart disease, lymphocyte ratio, Procalcitonin (PCT), and D-D dimers. Stephen, et al 17 developed a simple and practical 4C Mortality Score based on basic epidemiologic, clinical, and laboratory data to predict mortality among hospitalized patients with COVID-19. For COVID-19 ICU patients, Cheng, et al 18 combined chest radiographs and clinical data to build a d -Abstract Truncated-
pharmacology & pharmacy,infectious diseases